Huntington Bancshares Earnings Calls
| Release date | Apr 23, 2026 |
| EPS estimate | $0.228 |
| EPS actual | $0.260 |
| EPS Surprise | 13.94% |
| Revenue estimate | 2.567B |
| Revenue actual | 2.592B |
| Revenue Surprise | 0.98% |
| Release date | Jan 22, 2026 |
| EPS estimate | $0.331 |
| EPS actual | $0.310 |
| EPS Surprise | -6.32% |
| Revenue estimate | 2.202B |
| Revenue actual | 2.191B |
| Revenue Surprise | -0.500% |
| Release date | Oct 17, 2025 |
| EPS estimate | $0.375 |
| EPS actual | $0.400 |
| EPS Surprise | 6.81% |
| Revenue estimate | 2.048B |
| Revenue actual | 2.134B |
| Revenue Surprise | 4.18% |
| Release date | Jul 18, 2025 |
| EPS estimate | $0.334 |
| EPS actual | $0.380 |
| EPS Surprise | 13.74% |
| Revenue estimate | 1.972B |
| Revenue actual | 1.938B |
| Revenue Surprise | -1.72% |
Last 4 Quarters for Huntington Bancshares
Below you can see how HBAN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 18, 2025 |
| Price on release | $16.71 |
| EPS estimate | $0.334 |
| EPS actual | $0.380 |
| EPS surprise | 13.74% |
| Date | Price |
|---|---|
| Jul 14, 2025 | $17.07 |
| Jul 15, 2025 | $16.56 |
| Jul 16, 2025 | $16.64 |
| Jul 17, 2025 | $16.98 |
| Jul 18, 2025 | $16.71 |
| Jul 21, 2025 | $16.81 |
| Jul 22, 2025 | $16.66 |
| Jul 23, 2025 | $16.82 |
| Jul 24, 2025 | $16.64 |
| 4 days before | -2.11% |
| 4 days after | -0.419% |
| On release day | 0.598% |
| Change in period | -2.52% |
| Release date | Oct 17, 2025 |
| Price on release | $15.50 |
| EPS estimate | $0.375 |
| EPS actual | $0.400 |
| EPS surprise | 6.81% |
| Date | Price |
|---|---|
| Oct 13, 2025 | $15.90 |
| Oct 14, 2025 | $16.34 |
| Oct 15, 2025 | $16.21 |
| Oct 16, 2025 | $15.37 |
| Oct 17, 2025 | $15.50 |
| Oct 20, 2025 | $15.84 |
| Oct 21, 2025 | $15.94 |
| Oct 22, 2025 | $15.87 |
| Oct 23, 2025 | $15.86 |
| 4 days before | -2.52% |
| 4 days after | 2.32% |
| On release day | 2.19% |
| Change in period | -0.252% |
| Release date | Jan 22, 2026 |
| Price on release | $17.64 |
| EPS estimate | $0.331 |
| EPS actual | $0.310 |
| EPS surprise | -6.32% |
| Date | Price |
|---|---|
| Jan 15, 2026 | $17.95 |
| Jan 16, 2026 | $18.02 |
| Jan 20, 2026 | $17.99 |
| Jan 21, 2026 | $18.77 |
| Jan 22, 2026 | $17.64 |
| Jan 23, 2026 | $17.37 |
| Jan 26, 2026 | $17.34 |
| Jan 27, 2026 | $17.43 |
| Jan 28, 2026 | $17.06 |
| 4 days before | -1.73% |
| 4 days after | -3.29% |
| On release day | -1.56% |
| Change in period | -4.96% |
| Release date | Apr 23, 2026 |
| Price on release | $16.83 |
| EPS estimate | $0.228 |
| EPS actual | $0.260 |
| EPS surprise | 13.94% |
| Date | Price |
|---|---|
| Apr 17, 2026 | $16.85 |
| Apr 20, 2026 | $17.06 |
| Apr 21, 2026 | $16.97 |
| Apr 22, 2026 | $16.82 |
| Apr 23, 2026 | $16.83 |
| Apr 24, 2026 | $16.40 |
| Apr 27, 2026 | $16.53 |
| Apr 28, 2026 | $16.55 |
| Apr 29, 2026 | $16.31 |
| 4 days before | -0.119% |
| 4 days after | -3.09% |
| On release day | -2.55% |
| Change in period | -3.20% |
Huntington Bancshares Earnings Call Transcript Summary of Q1 2026
Huntington reported a strong Q1 2026 driven by organic growth and contributions from recent partnerships. Adjusted EPS was $0.37 (up 9% YoY) with adjusted PPNR up 36% and tangible book value up 9%. Core loan and deposit growth remained solid (organic loan growth ex-Cadence +1.5% QoQ; core deposits ex-Cadence +2.3% QoQ) while NIM expanded modestly in Q1 but full-year NIM guidance was lowered to the high 3.20% range (from mid-3.30s) largely due to a planned ~$4B increase in Fed cash and slightly slower loan growth/asset optimization. Fee income was a standout, prompting management to raise fee revenue growth guidance to 31–33% for 2026; capital markets, payments and wealth all performed notably well. Expense discipline continues: management tightened 2026 expense-growth guidance to the lower half of 32.5–33.5% and expects Q4 efficiency in the mid- to low-54% range as Veritex and Cadence synergies ramp. The company reiterated its 2027 targets — EPS $1.90–$1.93 and ROTCE 18–19% — and said it is on track to achieve them. Balance sheet and liquidity are emphasized as strengths (available contingent liquidity ≈173% of uninsured deposits; LCR 118%; adjusted CET1 within 9–10% operating range). Management expects Basel III Endgame to be constructive (management estimate: ~7.5–8% RWA reduction, ~80 bps reported CET1 benefit). Capital return remains a priority: $150M repurchased in Q1, year-to-date >$250M, $550M repurchase planned for 2026, and a new $3B share repurchase authorization approved. Credit metrics remained stable (NCOs 26 bps, criticized assets 4.3%, NPAs 72 bps); management is watching commercial real estate/construction and plans gradual portfolio optimization there. Overall, Huntington highlights a resilient, diversified operating model, integration progress on recent deals, strong fee momentum, continued expense discipline and clear targets for improved returns in 2027.
Sign In
Buy HBAN